Ad is loading...
FSSNX
Price
$30.08
Change
+$0.54 (+1.83%)
Updated
Nov 22 closing price
LZCOX
Price
$12.40
Change
+$0.21 (+1.72%)
Updated
Nov 22 closing price
Ad is loading...

FSSNX vs LZCOX

Header iconFSSNX vs LZCOX Comparison
Open Charts FSSNX vs LZCOXBanner chart's image
Fidelity Small Cap Index
Price$30.08
Change+$0.54 (+1.83%)
VolumeN/A
CapitalizationN/A
Lazard US Small Cap Equity Select Open
Price$12.40
Change+$0.21 (+1.72%)
VolumeN/A
CapitalizationN/A
FSSNX vs LZCOX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSSNX vs. LZCOX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a Buy and LZCOX is a Buy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 26.9B vs. LZCOX (41M). FSSNX pays higher dividends than LZCOX: FSSNX (1.36) vs LZCOX (0.00). FSSNX was incepted earlier than LZCOX: FSSNX (13 years) vs LZCOX (28 years). LZCOX is a more actively managed with annual turnover of: 53.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than LZCOX: FSSNX (0) vs LZCOX (2500). FSSNX annual gain was more profitable for investors over the last year : 36.08 vs. LZCOX (14.60). FSSNX return over 5 years is better than : 54.79 vs. LZCOX (-1.11).
FSSNXLZCOXFSSNX / LZCOX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years28 years-
Gain YTD20.28912.319165%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets26.9B41M65,610%
Annual Yield % from dividends1.360.00-
Returns for 1 year36.0814.60247%
Returns for 3 years5.63-21.26-26%
Returns for 5 years54.79-1.11-4,937%
Returns for 10 years94.28-23.44-402%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPTI0.850.07
+8.67%
Karyopharm Therapeutics
PTPI0.270.01
+5.02%
Petros Pharmaceuticals
LGND119.192.64
+2.27%
Ligand Pharmaceuticals
TXO18.240.23
+1.28%
TXO Partners LP
RVMD56.75-0.03
-0.05%
Revolution Medicines